TABLE 5.

The fitted^† slopes [%/mSv/year] for the adjusted (Table 4) and unadjusted (Table 2) data; uncertainties represent one standard deviation (68% CI, confidence intervals).

	Absolute increase of cancer deaths [%/mSv/year] (68% CI)		Relative risk‡ (RR) [%/mSv/year] (68% CI)
	adjusted results*	unadjusted results**	adjusted results*	unadjusted results**
all cancers	−0.30 (−0.45; −0.09)	−0.77 (−0.90; −0.44)	−1.17 (−1.51; −0.60)	−3.07 (−3.43; −2.18)
	(χ2 = 2.8; p=0.08)	(χ2 = 1.5; p=0.01)	(χ2 = 6.3; p=0.02)	(χ2 = 1.8; p=0.0003)
lung cancers	−0.19 (−0.48; +0.14)	−1.80 (−2.04; −1.18)	−0.82 (−1.55; +0.10)	−7.37 (−8.14; −5.40)
	(χ2 = 0.8; p=0.3)	(χ2 = 3.7; p=0.002)	(χ2 = 1.7; p=0.2)	(χ2 = 5.0; p=0.0001)

^†classical method of least squares parameter estimation with two degrees of freedom (effective dose uncertainties taken into consideration)

^‡results presented in Figs 4 and 5

^*see Table 4

^**see Table 2